Abstract 4464: Repurposing nebivolol with CPI-613 for triple-negative breast cancer: Linking <i>in-vitro</i> synergy to <i>in-vivo</i> exposure.

Mikayla Skillman, Diana S.-L. Chow, Benny Abraham Kaiparettu et al.|Cancer Research|2026

Cited by 0